Efficacy and Safety of HRS9531 Injections in Overweight or Obese Subjects

NCT06054698 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight or Obesity

Interventions

DRUG: HRS9531 injection
DRUG: HRS9531 injection Placebo

Sponsor

Fujian Shengdi Pharmaceutical Co., Ltd.